Venmax Drugs And Pharmaceuticals Ltd.
BSE: 531015
₹24.00
₹-0.06
(-0.25%)
As on 08-May-2026IST
Market cap
₹28 Cr
Revenue (TTM)
₹4 Cr
P/E Ratio
32
P/B Ratio
1.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹1 Cr
-
ROE
0 %
-
ROCE
-0.6 %
-
Industry P/E
59.42
-
EV/EBITDA
32.8
-
Debt to Equity
-0.1
-
Book Value
₹14.3
-
EPS
₹1.6
-
Face value
10
-
Shares outstanding
11,582,930
10 Years Aggregate
CFO
₹-1.95 Cr
EBITDA
₹-3.29 Cr
Net Profit
₹-0.26 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Venmax Drugs
| -3.8 | 0.1 | -14.9 | -11.8 | -- | -- | -- |
|
BSE Healthcare
| 7.1 | 11.7 | 10.9 | 10.9 | 26.2 | 14.1 | 11.7 |
|
Company
|
2025
|
|---|---|
|
Venmax Drugs
| 31.7 |
|
BSE Small Cap
| -6.6 |
|
BSE Healthcare
| -3.3 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Venmax Drugs
|
24.0 | 27.8 | 4.4 | 0.9 | -4.3 | 12.6 | 32 | 1.7 |
| 2,734.3 | 22,376.6 | 1,339.4 | 356.4 | 33.2 | 23.2 | 62.8 | 13.5 | |
| 787.1 | 15,438.1 | 7,266.8 | 627.5 | 11.9 | 12.6 | 24.5 | 2.8 | |
| 488.2 | 18,680.8 | 2,051.5 | 180.5 | 11.6 | 7.7 | 92.6 | 4.9 | |
| 753.0 | 18,644.2 | 5,365.6 | 595.0 | 16.6 | 13.3 | 31.3 | 3.7 | |
| 1,174.7 | 21,027.5 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 13.5 | 2.4 | |
| 1,835.2 | 21,047.8 | 1,419.3 | 20.1 | 8.4 | 0.5 | 1047.1 | 3.6 | |
| 179.9 | 23,893.2 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.9 | |
| 458.1 | 18,488.1 | 3,738.7 | 316.7 | 12.5 | 7.5 | 58.4 | 3.8 | |
| 1,606.5 | 26,110.9 | 3,373.0 | 199.0 | 12.6 | 5.9 | 122.6 | 5.3 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Venmax Drugs
Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable... alkaloids; Read more
-
Incorporated
1988
-
Chairman
--
-
Managing Director
--
-
Headquarters
Hyderabad, Telangana
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsNo News & Announcements are available.
FAQs for Venmax Drugs
What is the current share price of Venmax Drugs And Pharmaceuticals Ltd Today?
The share price of Venmax Drugs And Pharmaceuticals Ltd is ₹24.00 (BSE) as of 08-May-2026 IST. Venmax Drugs And Pharmaceuticals Ltd has given a return of -11.83% in the last 1 years.
What is the current PB & PE ratio of Venmax Drugs And Pharmaceuticals Ltd?
The P/E ratio of Venmax Drugs And Pharmaceuticals Ltd is 31.95 times as on 08-May-2026, a 46 discount to its peers’ median range of 59.42 times.
The P/B ratio of Venmax Drugs And Pharmaceuticals Ltd is 1.68 times as on 08-May-2026, a 54 discount to its peers’ median range of 3.62 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
-22.62
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Venmax Drugs And Pharmaceuticals Ltd?
The 52-week high and low of Venmax Drugs And Pharmaceuticals Ltd are Rs 36.96 and Rs 19.01 as of 08-May-2026.
What is the market cap of Venmax Drugs And Pharmaceuticals Ltd?
Venmax Drugs And Pharmaceuticals Ltd has a market capitalisation of ₹ 28 Cr as on 08-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Venmax Drugs And Pharmaceuticals Ltd?
Before investing in Venmax Drugs And Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.